Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis

Matthias H. Tschöp; Michael Stumvoll; Michael Ristow

doi:10.1016/j.cmet.2016.05.017

Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis

Matthias H. Tschöp
, Michael Stumvoll
, Michael Ristow

Medicine and Health

Helmholtz Zentrum München German Research Center for Environmental Health
German Centre for Diabetes Research (DZD)
University Hospital Leipzig
ETH Zürich

Research output: Contribution to journal › Short survey › peer-review

9 Scopus citations

Abstract

Type 2 diabetes is associated with increased risk of malignancies, whereas antidiabetic interventions like physical exercise or metformin reduce cancer incidence. A recent publication shows that one diabetes treatment approach, namely incretin-related DPP4 inhibitors, increases metastatic capacity by activating the antioxidant transcription factor NRF2 to decrease reactive oxygen species (ROS) levels.

Original language	English
Pages (from-to)	959-960
Number of pages	2
Journal	Cell Metabolism
Volume	23
Issue number	6
DOIs	https://doi.org/10.1016/j.cmet.2016.05.017
State	Published - 14 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.cmet.2016.05.017

Cite this

@article{5982b9f479fd4102ae32f8eb416150b0,

title = "Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis",

abstract = "Type 2 diabetes is associated with increased risk of malignancies, whereas antidiabetic interventions like physical exercise or metformin reduce cancer incidence. A recent publication shows that one diabetes treatment approach, namely incretin-related DPP4 inhibitors, increases metastatic capacity by activating the antioxidant transcription factor NRF2 to decrease reactive oxygen species (ROS) levels.",

author = "Tsch{\"o}p, \{Matthias H.\} and Michael Stumvoll and Michael Ristow",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = jun,

day = "14",

doi = "10.1016/j.cmet.2016.05.017",

language = "English",

volume = "23",

pages = "959--960",

journal = "Cell Metabolism",

issn = "1550-4131",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis

AU - Tschöp, Matthias H.

AU - Stumvoll, Michael

AU - Ristow, Michael

PY - 2016/6/14

Y1 - 2016/6/14

N2 - Type 2 diabetes is associated with increased risk of malignancies, whereas antidiabetic interventions like physical exercise or metformin reduce cancer incidence. A recent publication shows that one diabetes treatment approach, namely incretin-related DPP4 inhibitors, increases metastatic capacity by activating the antioxidant transcription factor NRF2 to decrease reactive oxygen species (ROS) levels.

AB - Type 2 diabetes is associated with increased risk of malignancies, whereas antidiabetic interventions like physical exercise or metformin reduce cancer incidence. A recent publication shows that one diabetes treatment approach, namely incretin-related DPP4 inhibitors, increases metastatic capacity by activating the antioxidant transcription factor NRF2 to decrease reactive oxygen species (ROS) levels.

UR - https://www.scopus.com/pages/publications/84975466423

U2 - 10.1016/j.cmet.2016.05.017

DO - 10.1016/j.cmet.2016.05.017

M3 - Short survey

C2 - 27304493

AN - SCOPUS:84975466423

SN - 1550-4131

VL - 23

SP - 959

EP - 960

JO - Cell Metabolism

JF - Cell Metabolism

IS - 6

ER -

Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this